Cancer Drugs Provide Positive Value In Nine Countries, But The United States Lags In Health Gains Per Dollar Spent-Reference-Cited by-同舟云学术

Cancer Drugs Provide Positive Value In Nine Countries, But The United States Lags In Health Gains Per Dollar Spent

Published:2016-05 Issue:5 Volume:35 Page:813-823
ISSN:0278-2715
Container-title:Health Affairs
language:en
Short-container-title:Health Affairs

Author:

Salas-Vega Sebastian¹,Mossialos Elias²

Affiliation:

1. Sebastian Salas-Vega is an LSE Health Scholar at the London School of Economics and Political Science, in the United Kingdom.

2. Elias Mossialos ( ) is the Brian Abel-Smith Professor of Health Policy at the London School of Economics and Political Science and a professor of health policy and management at the Institute of Global Health Innovation, Imperial College London.

Publisher

Health Affairs (Project Hope)

Subject

Health Policy

Reference17 articles.

1. The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts

2. An Analysis Of Whether Higher Health Care Spending In The United States Versus Europe Is ‘Worth It’ In The Case Of Cancer

3. New Analysis Reexamines The Value Of Cancer Care In The United States Compared To Western Europe

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Uptake and availability of new outpatient cancer medicines in 2010-2021 in Nordic countries – Survey for competent authorities;2023-06-26

2. Comparison of Cancer-Related Spending and Mortality Rates in the US vs 21 High-Income Countries;JAMA Health Forum;2022-05-27

3. Real-world Use of and Spending on New Oral Targeted Cancer Drugs in the US, 2011-2018;JAMA Internal Medicine;2021-12-01

4. Methodology for constructing scenarios for health policy research: The case of coverage decision-making for drugs for rare diseases in Canada;Technological Forecasting and Social Change;2021-10

5. Exploring the Role of Leadership in Facilitating Change to Improve Cancer Survival: An Analysis of Experiences in Seven High Income Countries in the International Cancer Benchmarking Partnership (ICBP);International Journal of Health Policy and Management;2021-08-04